Somero Enterprises Inc.
10 January 2007
10 January 2007
THIS DOCUMENT MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED IN OR INTO THE
UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR TO US PERSONS OR TO RESIDENTS,
NATIONALS OR CITIZENS OF CANADA, JAPAN OR AUSTRALIA.
Somero Enterprises, Inc.
('Somero' or 'the Company')
Section 198 Notification
Somero Enterprises, Inc. received notification on 9 January 2007 from The
Trustees of BT Pension Scheme, Hermes Pensions Management Ltd and Hermes
Investment Management Ltd, pursuant to Section 198 of the Companies Act 1985
that their interest in the Company is 4,111,130 shares in the Company,
representing 13.217% of the issued share capital of the Company.
The holding is registered as follows:
Registered Holders: Held on behalf of: Number of shares: % of issued capital:
BriTel Fund Nominees Trustees of BT 2,271,389 7.302
Ltd Pension Scheme1
Possfund Nominees Royal Mail Pension 1,839,741 5.915
Ltd Plan2
Total interest: 4,111,130 13.217
Note 1: Trustees of the BT Pension Scheme control Britel Fund Trustees Limited,
which is owner of Hermes Pensions Management Limited. Hermes Focus Asset
Management Limited, Hermes Investment Management Limited, Hermes Assured Limited
and Hermes SLP Limited are all subsidiaries of Hermes Pensions Management
Limited.
Note 2: Shares held on behalf of Royal Mail Pension Plan are managed by Hermes
Investment Management Limited.
Enquiries:
Edward Bridges / Harriet Keen / Matt Dixon
Financial Dynamics +44 (0)20 7831 3113
This announcement does not constitute or form part of any offer or invitation to
sell, or any solicitation of any offer to purchase, any securities of Somero
Enterprises, Inc. (the 'Company').
Neither this announcement nor any copy of it may be taken or transmitted into
the United States, Australia, Canada or Japan or to a resident, national or
citizen of the United States, Australia, Canada or Japan. The distribution of
this announcement in certain other jurisdictions may also be restricted by law
and persons into whose possession this announcement or any document or other
information referred to herein comes should inform themselves about and observe
any such restriction. Any failure to comply with these restrictions may
constitute a violation of the securities laws of any such jurisdiction.
No shares or stock in the Company have been nor will they be registered under
the applicable securities laws of Australia, Canada or Japan and may not be
offered or sold within Australia, Canada or Japan or to, or for the account or
benefit of citizens or residents of Australia, Canada or Japan.
'EBITDA' represents the Company's operating income plus amortisation of
intangibles and depreciation. EBITDA is not a measurement of the Company's
financial performance under generally accepted accounting principles in the
United States ('U.S. GAAP') and should not be considered as an alternative to
operating income, net income or any other performance measures derived in
accordance with U.S. GAAP, or as an alternative to U.S. GAAP cash flow from
operating activities as a measure of profitability or liquidity.
ENDS.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.